Trials / Completed
CompletedNCT00195767
Evaluate the Safety of Depakote Extended Release Tablets in the Treatment of Mania Associated With Bipolar Disorder in Children and Adolescents
An Open-Label Long-Term Study to Evaluate the Safety of Depakote Extended Release Tablets in the Treatment of Mania Associated With Bipolar Disorder in Children and Adolescents
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 150 (planned)
- Sponsor
- Abbott · Industry
- Sex
- All
- Age
- 10 Years – 17 Years
- Healthy volunteers
- Not accepted
Summary
To determine if long-term treatment, up to 6 months, with Depakote ER is safe and effective in the treatment of bipolar I disorder in children and adolescents.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | divalproex sodium |
Timeline
- Start date
- 2004-07-01
- First posted
- 2005-09-20
- Last updated
- 2007-03-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00195767. Inclusion in this directory is not an endorsement.